These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 27859269)
1. Homocysteine as a Pathological Biomarker for Bone Disease. Behera J; Bala J; Nuru M; Tyagi SC; Tyagi N J Cell Physiol; 2017 Oct; 232(10):2704-2709. PubMed ID: 27859269 [TBL] [Abstract][Full Text] [Related]
2. The role of homocysteine in bone remodeling. Vacek TP; Kalani A; Voor MJ; Tyagi SC; Tyagi N Clin Chem Lab Med; 2013 Mar; 51(3):579-90. PubMed ID: 23449525 [TBL] [Abstract][Full Text] [Related]
3. Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid. Vaes BL; Lute C; Blom HJ; Bravenboer N; de Vries TJ; Everts V; Dhonukshe-Rutten RA; Müller M; de Groot LC; Steegenga WT Calcif Tissue Int; 2009 May; 84(5):413-22. PubMed ID: 19363664 [TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Herrmann M; Tami A; Wildemann B; Wolny M; Wagner A; Schorr H; Taban-Shomal O; Umanskaya N; Ross S; Garcia P; Hübner U; Herrmann W Bone; 2009 Mar; 44(3):467-75. PubMed ID: 19056526 [TBL] [Abstract][Full Text] [Related]
5. The Effects of Homocysteine on the Skeleton. Saito M; Marumo K Curr Osteoporos Rep; 2018 Oct; 16(5):554-560. PubMed ID: 30116976 [TBL] [Abstract][Full Text] [Related]
6. One carbon metabolism and bone homeostasis and remodeling: A review of experimental research and population studies. Feigerlova E; Demarquet L; Guéant JL Biochimie; 2016 Jul; 126():115-23. PubMed ID: 27086080 [TBL] [Abstract][Full Text] [Related]
7. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. Koh JM; Lee YS; Kim YS; Kim DJ; Kim HH; Park JY; Lee KU; Kim GS J Bone Miner Res; 2006 Jul; 21(7):1003-11. PubMed ID: 16813521 [TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. Nojiri H; Saita Y; Morikawa D; Kobayashi K; Tsuda C; Miyazaki T; Saito M; Marumo K; Yonezawa I; Kaneko K; Shirasawa T; Shimizu T J Bone Miner Res; 2011 Nov; 26(11):2682-94. PubMed ID: 22025246 [TBL] [Abstract][Full Text] [Related]
10. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Škovierová H; Vidomanová E; Mahmood S; Sopková J; Drgová A; Červeňová T; Halašová E; Lehotský J Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775595 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Moshal KS; Metreveli N; Frank I; Tyagi SC Curr Vasc Pharmacol; 2008 Apr; 6(2):84-92. PubMed ID: 18393909 [TBL] [Abstract][Full Text] [Related]
12. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. Tyagi N; Kandel M; Munjal C; Qipshidze N; Vacek JC; Pushpakumar SB; Metreveli N; Tyagi SC J Orthop Res; 2011 Oct; 29(10):1511-6. PubMed ID: 21469179 [TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases? Petramala L; Acca M; Francucci CM; D'Erasmo E J Endocrinol Invest; 2009; 32(4 Suppl):10-4. PubMed ID: 19724160 [TBL] [Abstract][Full Text] [Related]
14. Bone tissue and hyperhomocysteinemia. Levasseur R Joint Bone Spine; 2009 May; 76(3):234-40. PubMed ID: 19217816 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial mechanism of oxidative stress and systemic hypertension in hyperhomocysteinemia. Tyagi N; Moshal KS; Ovechkin AV; Rodriguez W; Steed M; Henderson B; Roberts AM; Joshua IG; Tyagi SC J Cell Biochem; 2005 Nov; 96(4):665-71. PubMed ID: 16149054 [TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease. Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422 [TBL] [Abstract][Full Text] [Related]
17. Matrix imbalance by inducing expression of metalloproteinase and oxidative stress in cochlea of hyperhomocysteinemic mice. Kundu S; Tyagi N; Sen U; Tyagi SC Mol Cell Biochem; 2009 Dec; 332(1-2):215-24. PubMed ID: 19590937 [TBL] [Abstract][Full Text] [Related]
18. Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice. Rosenberger D; Gargoum R; Tyagi N; Metreveli N; Sen U; Maldonado C; Tyagi S Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):492-8. PubMed ID: 20227264 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine--a newly recognised risk factor for osteoporosis. Herrmann M; Widmann T; Herrmann W Clin Chem Lab Med; 2005; 43(10):1111-7. PubMed ID: 16197307 [TBL] [Abstract][Full Text] [Related]
20. Arterial stiffness is not associated with bone parameters in an elderly hyperhomocysteinemic population. van Dijk SC; de Jongh RT; Enneman AW; Ham AC; Swart KM; van Wijngaarden JP; van der Zwaluw NL; Brouwer-Brolsma EM; van Schoor NM; Dhonukshe-Rutten RA; Lips P; de Groot CP; Smulders YM; Blom HJ; Feskens EJ; Geleijnse JM; van den Meiracker AH; Mattace Raso FU; Uitterlinden AG; Zillikens MC; van der Velde N J Bone Miner Metab; 2016 Jan; 34(1):99-108. PubMed ID: 25804313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]